Skip to content
Brand AI

3B Pharmaceuticals GmbH

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2019

    Clovis Oncology and 3B Pharmaceuticals enter licensing and collaboration agreement

    Clovis Oncology and 3B Pharmaceuticals entered into a global licensing and collaboration agreement covering development of an FAP-targeted radiopharmaceutical programme and discovery work on three additional targets. Clovis obtained U.S. and global rights excluding Europe for the initial programme, while 3B Pharmaceuticals retained European rights.

    Source